We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

FDA Awards Breakthrough Therapy Designation to Boehringer’s Lung Cancer Candidate

News   Jan 06, 2016

 
FDA Awards Breakthrough Therapy Designation to Boehringer’s Lung Cancer Candidate
 
 
Advertisement
 

RELATED ARTICLES

University of New Hampshire Awarded $1.8 M To Explore Drug Interactions and Targeted Drug Development

News

The University of New Hampshire is set to receive $1.8 million from the National Institutes of Health. This will be used to further the university's research to better understand drug interactions at the cellular level and help develop new targeted drugs to treat disorders including diabetes and cancer.

READ MORE

Circular RNA Molecule ciRS-7 Not Found in Cancer Cells After All

News

A new research result from Aarhus University shows that a circular RNA molecule, which has been designated as carcinogenic, is actually not found in the cancer cells. Researchers suggest that the molecule contributes to the cancer developing through what is known as the microenvironment.

READ MORE

Ultrapotent Compound Could Help Combat C. difficile

News

Scientists from Purdue University have advanced novel compounds that they have designed to help treat patients with Clostridioides difficile.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE